Indeed, recent reports describe the inhibition of N-Myc in neuroblastoma cell lines with the small molecule 10058-F4 [35, 37], suggesting a similar, more potent effect may also be expected with our dimeric inhibitors. The gene discussed is MYCN; the disease is neuroblastoma.